Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Calcification of abdominal aorta is a high risk underappreciated cardiovascular disease factor in a general population

Anurag Sethi, Leland Taylor, J Graham Ruby, Jagadish Venkataraman, Elena Sorokin, Madeleine Cule, View ORCID ProfileEugene Melamud
doi: https://doi.org/10.1101/2020.05.07.20094706
Anurag Sethi
2Calico Life Sciences, LLC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leland Taylor
2Calico Life Sciences, LLC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Graham Ruby
2Calico Life Sciences, LLC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jagadish Venkataraman
2Calico Life Sciences, LLC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elena Sorokin
2Calico Life Sciences, LLC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Madeleine Cule
2Calico Life Sciences, LLC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: cule@calicolabs.com eugene@calicolabs.com
Eugene Melamud
2Calico Life Sciences, LLC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eugene Melamud
  • For correspondence: cule@calicolabs.com eugene@calicolabs.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Abdominal aortic calcification (AAC) is an important contributor to cardiovascular disease, however, prevalence of the pathology, risk factors, and disease outcomes in a general population have not been systematically analyzed.

Methods We have analyzed the prevalence of AAC in the UK Biobank cohort using machine learning models across 38,264 whole body dual-energy X-ray absorptiometry (DEXA) scans. We associated severity of calcification across a wide range of physiological parameters, clinical biomarkers, and environmental risk factors (406 in total). We further performed a rare and common variant genetic association study to identify genetic loci relevant to AAC and evaluated the prognostic value of AAC across 174 disease classes.

Results We find that AAC is highly prevalent in a general population (>10.4% of the cohort) despite low prevalence of diabetes (2.5%) and CKD (0.5%). Increased level of AAC is a strong prognostic indicator of a wide range of cardiovascular outcomes, including stenosis of precerebral arteries (HR∼1.5), myocardial infarction (HR∼1.36), ischemic heart disease (HR∼1.3), and chronic obstructive pulmonary disease (HR∼1.3). We report four genetic loci associated with AAC, three of which have not been previously reported. Surprisingly, we find that elevated but still within clinically normal levels of serum phosphate, serum calcium, and glycated hemoglobin are linked to increased vascular calcification.

Conclusions By our estimate, AAC is an LDL-independent risk factor for cardiovascular outcomes, with risk similar to elevated LDL. Development of anti-calcification therapeutics would complement lipid lowering strategies in reducing CVD burden.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by Calico Life Sciences LLC.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The UK Biobank has approved the study.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Additional DEXA scans from UK Biobank implied we had more power for all the analyses in the paper. We have also made the manuscript clearer and easier to read. In addition, we also performed RVAS with the participants for whom whole exome sequencing data is available.

  • ↵1 http://biobank.ctsu.ox.ac.uk/crystal/crystal/docs/DXA_explan_doc.pdf

Data Availability

Data:This research has been conducted using the UK Biobank Resource.

  • Abbreviations

    HbA1c
    glycated hemoglobin
    GGT
    gamma glutamyl transferase
    ApoA
    apolipoprotein
    HDL
    high density lipoprotein
    LDL
    low density lipoprotein
    WBC
    White blood cell
    MCV
    mean corpuscular volume
    MCHC
    mean corpuscular haemoglobin concentration
    RBC
    red blood cell, Imm.
    Reticulocyte
    immature reticulocyte
    IMT
    intima media thickness
    SBP
    systolic blood pressure
    PEF
    peak expiratory flow
    FVC
    forced vital capacity
    QUI
    quantitative ultrasound index, US- ultrasound
    BMD
    bone mineral density
    FEV1
    forced expiratory volume in 1 second
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted October 29, 2020.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Calcification of abdominal aorta is a high risk underappreciated cardiovascular disease factor in a general population
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Calcification of abdominal aorta is a high risk underappreciated cardiovascular disease factor in a general population
    Anurag Sethi, Leland Taylor, J Graham Ruby, Jagadish Venkataraman, Elena Sorokin, Madeleine Cule, Eugene Melamud
    medRxiv 2020.05.07.20094706; doi: https://doi.org/10.1101/2020.05.07.20094706
    Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
    Citation Tools
    Calcification of abdominal aorta is a high risk underappreciated cardiovascular disease factor in a general population
    Anurag Sethi, Leland Taylor, J Graham Ruby, Jagadish Venkataraman, Elena Sorokin, Madeleine Cule, Eugene Melamud
    medRxiv 2020.05.07.20094706; doi: https://doi.org/10.1101/2020.05.07.20094706

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Epidemiology
    Subject Areas
    All Articles
    • Addiction Medicine (216)
    • Allergy and Immunology (495)
    • Anesthesia (106)
    • Cardiovascular Medicine (1103)
    • Dentistry and Oral Medicine (196)
    • Dermatology (141)
    • Emergency Medicine (274)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (504)
    • Epidemiology (9787)
    • Forensic Medicine (5)
    • Gastroenterology (481)
    • Genetic and Genomic Medicine (2323)
    • Geriatric Medicine (223)
    • Health Economics (463)
    • Health Informatics (1566)
    • Health Policy (737)
    • Health Systems and Quality Improvement (606)
    • Hematology (238)
    • HIV/AIDS (507)
    • Infectious Diseases (except HIV/AIDS) (11658)
    • Intensive Care and Critical Care Medicine (617)
    • Medical Education (240)
    • Medical Ethics (67)
    • Nephrology (258)
    • Neurology (2149)
    • Nursing (134)
    • Nutrition (339)
    • Obstetrics and Gynecology (427)
    • Occupational and Environmental Health (518)
    • Oncology (1184)
    • Ophthalmology (366)
    • Orthopedics (129)
    • Otolaryngology (220)
    • Pain Medicine (148)
    • Palliative Medicine (50)
    • Pathology (313)
    • Pediatrics (698)
    • Pharmacology and Therapeutics (302)
    • Primary Care Research (267)
    • Psychiatry and Clinical Psychology (2192)
    • Public and Global Health (4676)
    • Radiology and Imaging (781)
    • Rehabilitation Medicine and Physical Therapy (457)
    • Respiratory Medicine (624)
    • Rheumatology (274)
    • Sexual and Reproductive Health (226)
    • Sports Medicine (211)
    • Surgery (252)
    • Toxicology (43)
    • Transplantation (120)
    • Urology (94)